Crawford & Company 10-Q Summary: Period Ended June 30, 2002
Business Context and Reporting Period
This Form 10-Q covers the quarterly and six-month periods ended June 30, 2002, for Crawford & Company, a provider of claims administration services operating in the U.S. and internationally. The company reported a significant decline in operating performance compared to the prior year, driven by reduced case volumes in the U.S. and foreign currency headwinds.
Key Financial Metrics
| Metric (Six Months Ended June 30) | 2002 (in thousands) | 2001 (in thousands) |
|---|---|---|
| Total Revenues | $364,350 | $382,380 |
| Net Income | $13,034 | $16,980 |
| Diluted EPS | $0.27 | $0.35 |
| Operating Cash Flow | $21,609 | $24,168 |
| Cash and Equivalents (End of Period) | $18,152 | $13,566 |
| Short-term Borrowings | $39,829 | $36,440 |
| Long-term Debt (Excl. Current) | $36,394 | $36,378 |
Quarterly Results (Ended June 30): Net income was $4.9 million ($0.10 diluted EPS) compared to $8.8 million ($0.18 diluted EPS) in the prior year quarter. Total revenues for the quarter were $185.8 million, down from $194.6 million.
Material Changes vs. Prior Period
- Revenue Decline: Total revenues decreased 4.7% year-over-year for the six months. U.S. revenues before reimbursements fell 4.6%, while International revenues fell 4.0%.
- Profitability Compression: Operating earnings dropped significantly. U.S. operating earnings fell 47.8% to $12.2 million, and International operating earnings fell 45.2% to $4.6 million.
- Case Volume: U.S. unit volume (excluding class actions) decreased 17.7% due to a decline in high-frequency, low-severity claims and the loss of two major fronting company accounts. International volume decreased 4.5% excluding acquisitions.
- Expense Ratios: Compensation as a percentage of revenue increased in both segments (U.S. to 64.4%, International to 68.9%) due to fixed capacity costs amidst declining volumes.
- Accounting Changes: Adoption of SFAS 142 eliminated goodwill amortization, adding approximately $1.4 million to year-to-date net income. A one-time $6.0 million nonrecurring credit from a vendor settlement in Q1 boosted earnings.
Outlook, Risks, and Management Commentary
- Dividend Reduction: Due to a lack of earnings improvement, the Board reduced the quarterly dividend to $0.06 per share (from $0.14) effective July 2002.
- Cost Reduction: Management initiated a freeze on salary increases and new hires, targeting $1.0 million in monthly cost reductions by Q3 2002.
- Legal Proceedings: The company is cooperating with a U.S. Department of Justice investigation regarding billing practices in certain U.S. offices. Expenses related to this investigation totaled $2.2 million for the six months ended June 30, 2002. The outcome remains uncertain and could result in fines or loss of clients.
- Contract Non-Renewal: A material contract for medical bill review services with a large U.S. insurer was not renewed in December 2001, resulting in a loss of $6.0 million in revenue through June 2002.
- Acquisitions: The company acquired Robertson & Company Group in Australia for $10.0 million in July 2002, with results expected to be included starting September 2002.
Investor Verification Checklist
- Verify the status and potential financial impact of the ongoing U.S. Department of Justice investigation into billing practices.
- Monitor the effectiveness of the $1.0 million monthly cost reduction initiative in stabilizing operating margins.
- Assess the sustainability of the reduced dividend payout ratio given the decline in net income.
- Review the integration and performance of the new Australian acquisition (Robertson & Company Group) in upcoming filings.
- Track the transition of the non-renewed medical bill review contract and the ramp-up of the new outsourcing arrangement with a U.S. property and casualty insurer.